(Q40807088)

English

Use of the hepatitis B recombinant DNA yeast vaccine (H-B-VAX II) in children: two doses vs. three doses of 5 micrograms regime; an interim report

scientific article published on July 1986

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Use of the hepatitis B recombinant DNA yeast vaccine (H-B-VAX II) in children: two doses vs. three doses of 5 micrograms regime; an interim report (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Lai CL

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Yeoh EK

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Chang WK

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Lo VW

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Ng LN

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 July 1986

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Journal of Infection

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

13 Suppl A

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

19-25

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Human hepatitis B vaccine from recombinant yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Postnatal infectivity of hepatitis B surface antigen-carrier mothers.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of hepatitis B virus infections in preschool children in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of hepatitis among students at a university in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of maternal-fetal transmission of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2886%2992623-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0163-4453(86)92623-X

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40807088&oldid=1907787944"